EcoR1 Capital as of June 30, 2023
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 52 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 19.4 | $791M | 12M | 68.28 | |
| Apellis Pharmaceuticals (APLS) | 12.2 | $497M | 5.5M | 91.10 | |
| Sarepta Therapeutics (SRPT) | 10.3 | $419M | 3.7M | 114.52 | |
| Johnson & Johnson Call Option (JNJ) | 6.9 | $281M | 1.7M | 165.52 | |
| Galapagos Nv Spon Adr (GLPG) | 5.7 | $234M | 5.8M | 40.66 | |
| Morphic Hldg (MORF) | 5.4 | $221M | 3.8M | 57.33 | |
| Revolution Medicines (RVMD) | 4.7 | $193M | 7.2M | 26.75 | |
| Anaptysbio Inc Common (ANAB) | 3.7 | $153M | 7.5M | 20.34 | |
| ACADIA Pharmaceuticals (ACAD) | 3.5 | $144M | 6.0M | 23.95 | |
| Xencor (XNCR) | 3.2 | $132M | 5.3M | 24.97 | |
| Zymeworks Del (ZYME) | 2.8 | $116M | 13M | 8.64 | |
| Blueprint Medicines (BPMC) | 2.8 | $114M | 1.8M | 63.20 | |
| Arvinas Ord (ARVN) | 2.4 | $100M | 4.0M | 24.82 | |
| Springworks Therapeutics (SWTX) | 2.2 | $91M | 3.5M | 26.22 | |
| Kura Oncology (KURA) | 1.6 | $67M | 6.3M | 10.58 | |
| Relay Therapeutics (RLAY) | 1.3 | $52M | 4.2M | 12.56 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.1 | $46M | 368k | 123.97 | |
| Voyager Therapeutics (VYGR) | 1.1 | $44M | 3.9M | 11.45 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.9 | $35M | 5.6M | 6.19 | |
| Edgewise Therapeutics (EWTX) | 0.7 | $27M | 3.5M | 7.75 | |
| Oric Pharmaceuticals (ORIC) | 0.6 | $27M | 3.4M | 7.76 | |
| Atea Pharmaceuticals (AVIR) | 0.6 | $26M | 7.0M | 3.74 | |
| Nuvation Bio Com Cl A (NUVB) | 0.6 | $25M | 14M | 1.80 | |
| Alector (ALEC) | 0.6 | $24M | 4.1M | 6.01 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.6 | $24M | 1.3M | 18.02 | |
| Allogene Therapeutics (ALLO) | 0.5 | $22M | 4.5M | 4.97 | |
| Graphite Bio | 0.5 | $22M | 8.5M | 2.60 | |
| Ovid Therapeutics (OVID) | 0.5 | $20M | 6.1M | 3.28 | |
| Ngm Biopharmaceuticals (NGM) | 0.4 | $17M | 6.4M | 2.59 | |
| Tango Therapeutics (TNGX) | 0.3 | $13M | 4.0M | 3.32 | |
| Tscan Therapeutics (TCRX) | 0.3 | $13M | 5.0M | 2.50 | |
| Generation Bio (GBIO) | 0.3 | $11M | 2.0M | 5.50 | |
| Third Harmonic Bio (THRD) | 0.2 | $10M | 2.1M | 4.81 | |
| Phathom Pharmaceuticals (PHAT) | 0.2 | $10M | 700k | 14.32 | |
| Dyne Therapeutics (DYN) | 0.2 | $9.0M | 799k | 11.25 | |
| Prime Medicine (PRME) | 0.2 | $8.8M | 600k | 14.65 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.2 | $8.5M | 300k | 28.21 | |
| Janux Therapeutics (JANX) | 0.1 | $5.4M | 453k | 11.87 | |
| Prelude Therapeutics (PRLD) | 0.1 | $5.2M | 1.2M | 4.50 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $4.8M | 3.0M | 1.62 | |
| Hookipa Pharma Inc equity (HOOK) | 0.1 | $4.0M | 4.6M | 0.88 | |
| Aligos Therapeutics (ALGS) | 0.1 | $3.8M | 3.9M | 0.97 | |
| Allakos (ALLK) | 0.1 | $3.3M | 749k | 4.36 | |
| Aeglea Biotherapeutics | 0.1 | $2.3M | 5.0M | 0.45 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $1.7M | 963k | 1.80 | |
| Tempest Therapeutics (TPST) | 0.0 | $1.4M | 1.1M | 1.27 | |
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $1.2M | 67k | 18.07 | |
| Poseida Therapeutics I (PSTX) | 0.0 | $1.2M | 676k | 1.76 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $793k | 67k | 11.89 | |
| Kronos Bio (KRON) | 0.0 | $562k | 327k | 1.72 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $311k | 100k | 3.11 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $37k | 67k | 0.55 |
